About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 1490 record(s)
Req # A-2022-000816
The most current Canadian Risk Management Plan (RMP) or Canadian Addendum to the RMP and Canadian RMP review report for NEUPOGEN by Amgen Canada Inc., Drug Identification Numbers (DINs) 01968017, 02420104, and 02420112.Organization: Health Canada
December 2022
Req # A-2022-000835
All expense claims and receipts above one hundred dollars from November 20th, 2019 to September 20th, 2022 incurred by the Minister of Health Canada and the Chief of Staff.Organization: Health Canada
December 2022
Req # A-2022-000854
The initial cover letter indicating the brand name of the reference drug product and the dosage form of the generic drug in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-09-16 for the medicinal ingredient glatiramer. The Screening Acceptance Letter from Health Canada to the generic drug manufacturer confirming completion of screening of the Abbreviated New Drug Submission (ANDS) for glatiramer which appears in Health Canada’s list of “Generic Drug Submissions Under Review” dated 2022-09-16.Organization: Health Canada
December 2022
Req # A-2022-000873
Information for all complaints posted against Signatories of the letter (healthcare workers) and involvement of HLS Therapeutics - in relation to health product advertising incidents. All information in relation to incidents received by Health Canada and those referred to an Advertising Preclearance Agency (APA) from 2021-01-01- 2022-09-27 in regards to product Clozapine. All information in relation to complaints regarding the direct-to-consumer advertising of unauthorized claims.Organization: Health Canada
December 2022
Req # A-2022-000990
Any cancellation letter(s)/ correspondence which prompted the removal of Degarelix acetate from the Generic Drugs Under Review List dated October 20, 2022.Organization: Health Canada
December 2022
Req # A-2022-001075
All documents related to the negotiation and signing of a contribution agreement regarding the $100 million investment in the Norway House Cree Nation (NHCN) Health Centre of Excellence (HCE) by the Government of Canada announced September 7, 2018, intended to transfer all health services from Norway House Hospital, currently federally run, to NHCN upon completion of the new facility. Contribution agreement signed between Indigenous Services Canada and he NHCN Health Centre of Excellence Ltd. All correspondence and negotiation materials between Norway House Cree Nation and the federal government on the matter of transferring the Norway House Indian Hospital to local community control dating from January 1, 1995 to December Nov 1, 2022.Organization: Health Canada
December 2022
Req # A-2022-001079
All documents related to the Government of Ontario and the Government of Canada’s commitment to replace the Weeneebayko General Hospital and the provincially run James Bay General Hospital with a new hospital under the authority of the Weeneebayko Area Health Authority (WAHA), now known as the “Weeneebayko Area Health Authority Redevelopment Project”. Date range January 1, 2005 to November 15, 2022.Organization: Health Canada
December 2022
Req # A-2022-001092
Health Canada International Affairs Team, Strategic Horizontal Policy Division, Health Products and Food Branch. the International Affairs Team, position number 00157831. How many new employees were hired under this position from the periods of 2017-2019 and 2019-2022. The rate of how long they stayed.Organization: Health Canada
December 2022
Req # A-2022-001159
A detailed and itemized list of all costs associated with the May 17 to 19, 2022 visit to Canada by the (then) Prince of Wales and the Duchess of Cornwall.Organization: Health Canada
December 2022
Req # A-2022-00049/CH
I am asking for access to 1- the number of complaints your office received 2- the number of complaints your office refused or ceased to investigate along with the reasons from January 1, 2019 to November 6, 2022, by each month during that timeframe.Organization: Office of the Information Commissioner of Canada
December 2022